- $2.94bn
- $3.36bn
- $1.00bn
- 61
- 17
- 88
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 397 | 500 | 619 | 822 | 1,000 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 386 | 484 | 629 | 855 | 990 |
Operating Profit | 10.8 | 15.8 | -10.1 | -32.8 | 10.4 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.5 | 14.9 | -54.6 | 11.1 | 44.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.21 | 10 | -61.4 | 4.08 | 28.2 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.21 | 10.2 | -46.4 | 32.1 | 20.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.21 | 10.2 | -46.4 | 32.1 | 15.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.051 | 0.123 | -0.563 | 0.131 | 0.073 |
Dividends per Share |